ȸ¿ø°ø°£

Korean Society of Gastrointestinal Cancer Research

°øÁö»çÇ×

Á¦2ȸ ´ëÇѼÒÈ­±âÇ׾Ͽ¬±¸È¸ ½ÉÆ÷Áö¾ö

°ü¸®ÀÚ hit 1181 date 2006-08-30
¾È³çÇϽʴϱî?


¹«´õ¿î ¿©¸§ÀÌ ³¡³ª°¡°í °¡À»ÀÌ ´Ù°¡¿À°í ÀÖ½À´Ï´Ù. ¼±»ý´Ôµé²²¼­ ±â¿øÇϽô ¸ðµç ÀÏ¿¡¼­ °Ç½ÂÇϽñæ Áø½ÉÀ¸·Î ±â¿øÇϸç, ±× µ¿¾È ´ëÇѼÒÈ­±âÇ׾Ͽ¬±¸È¸¿¡ º¸³»ÁֽŠ¿©·¯ºÐµéÀÇ ÈÄ¿ø°ú °Ý·Á¿¡ °¨»ç µå¸³´Ï´Ù.
2006³â 4¿ù 8ÀϠ⸳ ÃÑȸ ¹× Á¦1ȸ ´ëÇѼÒÈ­±âÇ׾Ͽ¬±¸È¸ ½ÉÆ÷Áö¾öÀ» ¸¹Àº ¼ÒÈ­±â³»°ú ¼±»ý´ÔµéÀÇ ¿­È­¿Í °°Àº ¼º¿ø¿¡ ÈûÀԾº°øÀûÀ¸·Î ³¡³»°í 2006³â 9¿ù 9ÀÏ Á¦2ȸ ´ëÇѼÒÈ­±âÇ׾Ͽ¬±¸È¸ ½ÉÆ÷Áö¾öÀ» °³ÃÖÇÏ°Ô µÇ¾ú½À´Ï´Ù. À̹ø ½ÉÆ÷Áö¾ö¿¡¼­´Â ¸¹Àº ±¹³»¿Í ±¹¿Ü ¿¬ÀÚ ºÐµéÀ» ¸ð½Ã°í Áö±Ý±îÁöÀÇ Ç×¾ÏÄ¡·á¿Í ¾ÕÀ¸·ÎÀÇ Ä¡·á¹æ¹ýÀ» »ìÆ캸¸é¼­ ¼ÒÈ­±â¾Ï¿¡¼­ ¼ÒÈ­±â³»°ú ÀÇ»çÀÇ ¿ªÇÒ¿¡ ´ëÇÏ¿© ±¹³»¿Ü ÇöȲÀ» µ¹¾Æº¸´Â ½Ã°£À» °®°íÀÚ ÇÕ´Ï´Ù.
ºÎµð ½ÉÆ÷Áö¾öÀ» ÅëÇØ ¿©·¯ ¼±»ý´Ôµé²²¼­ ¼ÒÈ­±â¾Ï¿¡ ´ëÇÑ ¿¬±¸¿Í È¯ÀÚ¸¦ Áø·áÇϽôµ¥ µµ¿òÀÌ µÇ±â¸¦ ¹Ù¶ó¿À¸ç, ¿©·¯ ¼±»ý´ÔµéÀÇ ¸¹Àº °Ý·Á¿Í Âü¿© ºÎŹ µå¸³´Ï´Ù.


2006³â 8¿ù
´ëÇѼÒÈ­±âÇ׾Ͽ¬±¸È¸ ¿î¿µÀ§¿ø Àϵ¿


µî·Ïºñ: ¹«·á
»çÀüµî·Ï¸¶°¨ÀÏ: 2006³â 9¿ù 7ÀÏ
½Åû: ¼º¸í, ¼Ò¼Ó, ¿¬¶ôó, ÀÇ»ç¸éÈ£¹øÈ£, Àü¹®ÀǹøÈ£ µîÀÇ ÀÎÀû»çÇ×À» ¿ìÆí, FAX ¶Ç´Â e-mail·Î º¸³»Áֽðųª ÀüÈ­·Î ¿¬¶ôÇØ Áֽñ⠹ٶø´Ï´Ù.
ÁÖ¼Ò: ¼­¿ï½Ã ¼­´ë¹®±¸ ½ÅÃ̵¿ 134 ¿¬¼¼ÀÇ´ë 316È£ (¿ì)120-752
Tel : 02-2228-1958
Fax: 02-2227-7900
E-mail : snlee@yumc.yonsei.ac.kr


 
Á¦2ȸ ´ëÇѼÒÈ­±âÇ׾Ͽ¬±¸È¸ ½ÉÆ÷Áö¾ö


ÀϽÃ: 2006³â 9¿ù 9ÀÏ (Åä)
Àå¼Ò: ¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇР°­´ç


8:30-9:00 Registration
9:00-09:05 Opening Remark                                                        


09:05-10:35  Session I: Comprehension of Chemotherapeutic Agents for GI Cancer
09:05-09:25: Conventional Chemotherapeutic Agents                           
09:30-09:50: Emerging New Chemotherapeutic Agents                              
09:55-10:10: Oral Anticancer Agents                                            
10:15-10:30: Humanized Monoclonal Antibody Treatment                           


10:35-10:55  Coffee Break


10:55-12:10  Session II: Management of Complications in Anti-Cancer Treatment
10:55-11:15: GI-related Complications                                        
11:20-11:40: Hematological Complications                                      
11:45-12:05: Dose Modification in Comorbid Illness                       


12:10-13:10  Lunch


13:10-13:40 Special Lecture                                                  
Experience of Anti-cancer Treatment for GI Cancer in Japan     


13:40-14:00 Coffee Break


14:00-15:50  Session III: ¼ÒÈ­±â¾Ï¿¡¼­ÀÇ ¼ÒÈ­±â Àü°øÀÇ»çÀÇ ¿ªÇÒ        
14:00-14:20: À§Àå°ü¾Ï¿¡¼­ÀÇ ¿ªÇÒ                                              
14:20-14:40: °£´ãÃéÀå¾Ï¿¡¼­ÀÇ ¿ªÇÒ                                               
14:40-15:00: ¼ÒÈ­±â³»°ú Ç×¾ÏÄ¡·áÀÇ ±¹³» ÇöȲ                                     
15:00-15:20: Ç×¾ÏÈ­Çпä¹ý °ø°í¾È°ú ¾ÏÁúȯ ½ÉÀÇÀ§¿øȸÀÇ ¿ªÇÒ                      
15:20-15:50: ÆгÎÅäÀÇ 
        
                               
Closing Remark
÷ºÎÆÄÀÏ
÷ºÎÆÄÀÏÀÌ ¾ø½À´Ï´Ù.
¸ñ·Ï